Anti-BPGM aptamer SELEX Service(Cat#: CTApt-1782)

This is an aptamer development services to screening aptamers binds to the BPGM with an affinity of 1nM~1μM.

Specific Inquiry 
Size
5’ Modification
 
3’ Modification
 
Add To
Online Inquiry

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number

TOP
Summary

Specifications
Target Category Protein
Target BPGM
Alternative Names Bisphosphoglycerate Mutase; 2,3-Bisphosphoglycerate Mutase, Erythrocyte; 2,3-Bisphosphoglycerate Synthase; 2,3-Diphosphoglycerate Mutase; BPG-Dependent PGAM; DPGM; Testis Secretory Sperm-Binding Protein Li 202a; Erythrocyte 2,3-Bisphosphoglycerate Mutase; 2,3-Bisphosphoglycerate Mutase; EC 5.4.2.11; EC 5.4.2.4; ECYT8; BPGM
Gene ID 669
UniProt ID P07738
Target Overview 2,3-diphosphoglycerate (2,3-DPG) is a small molecule found at high concentrations in red blood cells where it binds to and decreases the oxygen affinity of hemoglobin. This gene encodes a multifunctional enzyme that catalyzes 2,3-DPG synthesis via its synthetase activity, and 2,3-DPG degradation via its phosphatase activity. The enzyme also has phosphoglycerate phosphomutase activity. Deficiency of this enzyme increases the affinity of cells for oxygen. Mutations in this gene result in hemolytic anemia. Multiple alternatively spliced variants, encoding the same protein, have been identified.
Chemical Modification N/A
Type DNA
Length 20-80 nt
Affinity (Kd) 1nM~1μM
Binding Conditions/Buffer PBS; buffer system with Serum; other
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
Online Inquiry